Physician

Jonathan David Wilkerson, M.D.

According to 2025 Medicare claims, Jonathan Wilkerson, M.D. (NPI: 1235326737) practices nephrology in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is KIDNEY SPECIALISTS OF PADUCAH PLLC (NPI: 1740765957; TIN: 831141225) and primary practice location at 42003-7942. Wilkerson is affiliated with the IRCCO (ACO ID: A2619), The Rural Advantage LLC (ACO ID: A5257), and IHCI ACO Midwest LLC (ACO ID: A5516), participating under the MSSP model.

Wilkerson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 881 traditional Medicare patients, billed 4,916 HCPCS/CPT codes, and received $301,589 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,215 prescription claims across 425 beneficiaries totaling $702,564 in drug costs, led by Farxiga (Dapagliflozin Propanediol). Open Payments data shows 92 records totaling $1,747. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $204,466 to $702,564. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,114	7,016	$364,736
2016	1,140	8,495	$423,769
2017	1,141	5,746	$421,289
2018	1,166	5,026	$431,321
2019	1,212	4,692	$420,457
2020	1,175	5,490	$405,254
2021	1,195	6,197	$437,898
2022	1,062	5,803	$359,613
2023	920	5,132	$294,894
2024	881	4,916	$301,589

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	323	1,869	$204,466
2016	419	2,427	$278,340
2017	390	2,395	$338,577
2018	420	2,287	$223,880
2019	442	2,417	$276,220
2020	440	2,371	$325,466
2021	495	2,338	$293,068
2022	464	2,126	$217,653
2023	442	2,271	$527,143
2024	425	2,215	$702,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	116	130	$139
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	98	98	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	453	801	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	236	748	$63
90935	Hemodialysis procedure with physician evaluation	104	230	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	307	16,830	$306,203
Rayaldee	Calcifediol	65	2,190	$89,061
Kerendia	Finerenone	66	3,180	$66,559
Veltassa	Patiromer Calcium Sorbitex	24	1,380	$44,565
Jardiance	Empagliflozin	40	2,040	$38,902

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	92	$1,747	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan David Wilkerson, M.D.?

Tedicare shows public-source Medicare data for Jonathan David Wilkerson, M.D. (NPI 1235326737), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan David Wilkerson, M.D. have ACO affiliation data?

Jonathan David Wilkerson, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), The Rural Advantage LLC (MSSP, ACO ID A5257), and IHCI ACO Midwest LLC (MSSP, ACO ID A5516).

What billing organization is linked to Jonathan David Wilkerson, M.D.?

Jonathan David Wilkerson, M.D. is linked to KIDNEY SPECIALISTS OF PADUCAH PLLC (billing NPI 1740765957) in the available physician profile data.

Does Jonathan David Wilkerson, M.D. have Open Payments data?

Jonathan David Wilkerson, M.D. has 92 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.